Treatment
Comparator clinical trials
We’re tracking 1,699 recruiting studies that include Comparator, each written for real people, not researchers, below.
Recruiting studies
- NCT07289360Recruiting
Bootle Blast trial for teens with cerebral palsy
This study tests a video game designed to help children with hemiplegic cerebral palsy improve use of their affected hand. Kids play at home for 12 weeks and come to the clinic 3 times.
Ajax, OntarioAges 6–17 - NCT07292857Recruiting
Respiratory infection risk in postmenopausal women on HRT or not
This study looks at how the risk of respiratory infections (like colds or flu) may differ in postmenopausal women who use hormone replacement therapy (HRT) and those who do not. You will wear a smartwatch for six months and track your health through a smartphone app.
BernAges 40–60 - NCT07291336RecruitingPhase 4
Comparing two ways to place dental implants
This trial compares two methods for placing dental implants in the upper jaw: dynamic navigation (real-time guidance) versus static navigation (using a surgical guide). It aims to see which technique is more accurate for people missing one tooth between the right and left second premolars.
CairoAges 22–60 - NCT07289789Recruiting
Breathing and Neck Exercises for Asthma with Forward Head Posture
This study tests whether Buteyko or Pilates breathing, combined with neck exercises, can improve lung function and chest expansion in people with asthma and forward head posture. It may help you breathe better if your asthma is under control and you have that posture issue.
IslamabadAges 18–40 - NCT05965830Recruiting
Diaphragm testing in babies using ultrasound or a breathing-recording test
This study compares two ways to measure how well a baby’s diaphragm (main breathing muscle) works in babies and children who need breathing support. It may help doctors choose the best test to guide safe breathing changes, like when to remove the breathing tube or support.
LeidenAges birth–1 year - NCT07282613RecruitingPhase 3
CagriSema for blood sugar and weight in children with type 2 diabetes
This study tests a new medicine called CagriSema to see if it can lower blood sugar and help with weight loss in children and teens with type 2 diabetes. It compares the medicine to a placebo (a look-alike with no active drug) over several months.
New Haven, ConnecticutAges 10–18 - NCT07284602RecruitingPhase 3
Comparing a new drug to pirfenidone for lung scarring
This trial tests a new medicine, LYT-100 (deupirfenidone), against the standard drug pirfenidone for people with idiopathic pulmonary fibrosis (IPF). It aims to see if the new drug works better or has fewer side effects.
Palm Spring, CaliforniaAges 40 years+ - NCT07286331RecruitingPhase 3
New drug vs chemo for advanced endometrial cancer
This trial tests a new drug (mocertatug rezetecan) compared to standard chemotherapy for people with endometrial cancer that has progressed after platinum-based chemo and immunotherapy. It may help if your tumor has a protein called B7-H4.
Birmingham, AlabamaAges 18 years+ - NCT07282678Recruiting
Adaptive brain stimulation for treatment-resistant depression.
This study tests a new brain stimulation device that adjusts its signal in real time to treat depression. It's for people who haven't gotten enough help from antidepressants and are looking for a non-drug option.
Durham, North CarolinaAges 22 years+ - NCT07285005RecruitingPhase 3
Study of an oral drug for venous, lymphatic, and certain overgrowth syndromes
This trial tests whether the study drug KP-001 can help reduce symptoms like pain, fatigue, or bleeding caused by certain vascular malformations (abnormal blood vessel growths) that can't be surgically removed or haven't responded to other treatments. It's for people age 2 and older with specific conditions such as common venous malformations, lymphatic malformations, or KTS/CLOVES syndrome.
Charleston, South CarolinaAges 2 years+ - NCT06853743RecruitingPhase 2
Study of nicotinamide riboside for Huntington's disease
This trial tests if a vitamin B3-like supplement, nicotinamide riboside, can help people with early to mid-stage Huntington's disease. You will be randomly assigned to take the supplement or a placebo to see if it slows the disease.
OsloAges 18–80 - NCT07281092Recruiting
Comparing ADHD therapy options for teens
This study compares two types of therapy—organizational skills training and mindfulness—to see which helps teens with ADHD more. You'll attend group sessions and learn skills to help with focus, planning, and managing daily life.
Seattle, WashingtonAges 13–17 - NCT07287280Recruiting
Predicting surgery complications in gynecologic cancer
This study is comparing two different tools that doctors use to predict complications from gynecologic cancer surgery. The goal is to see which tool works better for planned (non-emergency) surgeries.
BangkokAges 18 years+ - NCT07287514Recruiting
Test of two oils on metabolism in adults with insulin resistance
This study compares an oil rich in linoleic acid (a type of omega-6 fat) against a blend oil to see which one better improves metabolism and heart health in people with insulin resistance. It may help if you have insulin resistance and at least one heart risk factor like belly fat, low good cholesterol, or high blood pressure.
Santiago, Santiago MetropolitanAges 20–60 - NCT07282912RecruitingPhase 2
Extra treatment for certain digestive cancers with undetectable ctDNA
This trial tests if adding extra local treatments (like surgery or radiation) to usual care can improve outcomes for people with certain advanced digestive cancers that have spread to a limited number of sites. You may be eligible if your cancer has responded well to at least 4 months of therapy and your ctDNA (a sign of cancer in the blood) is undetectable.
New Haven, ConnecticutAges 18–80 - NCT07280455Recruiting
Comparing gold vs. steel retainers after braces
This study compares two types of fixed retainers (gold vs. stainless steel) to see which works better after braces are removed. It's for people aged 15–30 who have completed orthodontic treatment and have a well-aligned lower front teeth.
Baghdad, Baghdad GovernorateAges 15–30 - NCT04794777RecruitingPhase 3
Tests targeted scans and rescue radiation for returning prostate cancer
This trial studies whether a targeted scan (PSMA PET/CT) can help doctors choose the best “salvage” radiation treatment when prostate cancer comes back by PSA blood tests after surgery. It may help some people avoid under- or over-treating the areas where the cancer is returning.
Gothenburg, GöteborgAges 18 years+ - NCT05087667Recruiting
Polymer wiring for arm or thigh fractures: tested vs standard care
This trial compares a new type of polymer cerclage (a strong wire used to support a fracture) against standard cerclage wiring used in routine care. It may help doctors learn which option works better for healing in certain arm (humerus) or thigh (femur) fractures.
Agen, FranceAges 18 years+ - NCT06884098RecruitingPhase 1
A study comparing two versions of a medicine in healthy adults
This trial tests a new version of a medicine (AD-228B) against the original (AD-2284) to see how they work in the body and if they are safe. Healthy volunteers are needed.
SeoulAges 19 years+ - NCT06846970Recruiting
Hot spring therapy plus physical therapy for chronic back pain
This study tests whether adding hot spring therapy (balneotherapy) to a standard physical therapy program can improve pain and function for people with chronic nerve-related back pain. It may help if you have long-term sciatica-like pain and have not had recent hot spring treatments.
Afyonkarahisar, CentralAges 18–75 - NCT07275450Recruiting
Ultrasound-guided numbing vs general anesthesia for ear surgery
This study compares numbing the ear with ultrasound guidance versus general anesthesia for tympanoplasty (eardrum repair). It aims to see which method offers better pain control and recovery.
ZagazigAges 21–65 - NCT07276399RecruitingPhase 3
Study of amivantamab plus standard care for head and neck cancer
This trial tests whether adding the drug amivantamab to usual treatments helps people with advanced head and neck cancer that has come back or spread. It compares the combination to standard care alone.
Chandler, ArizonaAges 18 years+ - NCT07277231RecruitingPhase 3
Comparing two drug combinations for untreated CLL
This trial tests a new combination of drugs (sonrotoclax plus zanubrutinib) against another standard combination (venetoclax plus acalabrutinib) for people with chronic lymphocytic leukemia (CLL) who have not had treatment before. The goal is to see which combination works better.
Duarte, CaliforniaAges 18 years+ - NCT07269847Recruiting
Beef-heavy diet study for adults with pre-diabetes
This study tests whether a diet rich in beef can improve metabolic health in adults with pre-diabetes or metabolic syndrome compared to a typical healthy U.S. diet. Eligible participants will follow one of two meal plans for several weeks.
Guelph, Ontario - onAges 18–74
Common questions
- Are there clinical trials studying Comparator?
- Yes. Clin2 currently lists 1,699 recruiting studies that include Comparator, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Comparator trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Comparator an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Comparator or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.